XIAO I CORP (AIXI)

US98423X1000 - ADR

5.2476  +0.14 (+2.8%)

Premarket: 6.3 +1.05 (+20.05%)

Fundamental Rating

2

Taking everything into account, AIXI scores 2 out of 10 in our fundamental rating. AIXI was compared to 280 industry peers in the Software industry. AIXI may be in some trouble as it scores bad on both profitability and health. AIXI is valued quite expensive, but it does show an excellent growth.



1

1. Profitability

1.1 Basic Checks

AIXI had negative earnings in the past year.
AIXI had a negative operating cash flow in the past year.

1.2 Ratios

AIXI has a worse Return On Assets (-67.93%) than 88.17% of its industry peers.
Industry RankSector Rank
ROA -67.93%
ROE N/A
ROIC N/A
ROA(3y)-13.94%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

AIXI has a Gross Margin of 69.94%. This is comparable to the rest of the industry: AIXI outperforms 54.84% of its industry peers.
In the last couple of years the Gross Margin of AIXI has grown nicely.
The Profit Margin and Operating Margin are not available for AIXI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 69.94%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.68%
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

AIXI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AIXI has about the same amount of shares outstanding.
Compared to 1 year ago, AIXI has an improved debt to assets ratio.

2.2 Solvency

AIXI has an Altman-Z score of -2.74. This is a bad value and indicates that AIXI is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of AIXI (-2.74) is worse than 79.93% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.74
ROIC/WACCN/A
WACC12.03%

2.3 Liquidity

AIXI has a Current Ratio of 0.66. This is a bad value and indicates that AIXI is not financially healthy enough and could expect problems in meeting its short term obligations.
AIXI has a worse Current ratio (0.66) than 88.89% of its industry peers.
AIXI has a Quick Ratio of 0.66. This is a bad value and indicates that AIXI is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.66, AIXI is not doing good in the industry: 88.17% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.66
Quick Ratio 0.66

7

3. Growth

3.1 Past

AIXI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -689.27%.
The Revenue has grown by 40.29% in the past year. This is a very strong growth!
The Revenue has been growing by 62.23% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-689.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-355.63%
Revenue 1Y (TTM)40.29%
Revenue growth 3Y62.23%
Revenue growth 5YN/A
Sales Q2Q%22.79%

3.2 Future

AIXI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 34.14% yearly.
AIXI is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 22.78% yearly.
EPS Next Y40.95%
EPS Next 2Y34.14%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year22.85%
Revenue Next 2Y22.78%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

1

4. Valuation

4.1 Price/Earnings Ratio

AIXI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AIXI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

AIXI's earnings are expected to grow with 34.14% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.14%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for AIXI!.
Industry RankSector Rank
Dividend Yield N/A

XIAO I CORP

NASDAQ:AIXI (12/24/2024, 7:54:51 PM)

Premarket: 6.3 +1.05 (+20.05%)

5.2476

+0.14 (+2.8%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)10-15 2024-10-15
Earnings (Next)N/A N/A
Inst Owners0.08%
Inst Owner Change-78.15%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap50.56M
AnalystsN/A
Price Target18.36 (249.87%)
Short Float %2%
Short Ratio1.38
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.59
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-4.7
EYN/A
EPS(NY)-1.62
Fwd EYN/A
FCF(TTM)-1.87
FCFYN/A
OCF(TTM)-1.64
OCFYN/A
SpS8.89
BVpS-0.5
TBVpS-0.53
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -67.93%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 69.94%
FCFM N/A
ROA(3y)-13.94%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.68%
GM growth 5YN/A
F-Score4
Asset Turnover1.29
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 318.37%
Cap/Sales 2.58%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.66
Quick Ratio 0.66
Altman-Z -2.74
F-Score4
WACC12.03%
ROIC/WACCN/A
Cap/Depr(3y)129.35%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.34%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-689.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-355.63%
EPS Next Y40.95%
EPS Next 2Y34.14%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)40.29%
Revenue growth 3Y62.23%
Revenue growth 5YN/A
Sales Q2Q%22.79%
Revenue Next Year22.85%
Revenue Next 2Y22.78%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-2291.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-63.14%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-44.55%
OCF growth 3YN/A
OCF growth 5YN/A